← Back to Clinical Trials
Recruiting NCT06600737

Greater Manchester CARDIOvascular Pathology in Immune-Mediated Inflammatory Diseases

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Cardiovascular Diseases
Sponsor University of Manchester
Study Type OBSERVATIONAL
Phase N/A
Enrollment 325
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-09-30
Completion 2032-09-01

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The researchers would like to know more about cardiovascular abnormalities in patients with immune-mediated inflammatory diseases (IMID) and with the aim to provide new biomarkers (clinical, blood, imaging) for early diagnosis, prognosis and prediction of CVD in patients with IMID. This is important as there are still many things that are not known about this and finding out more could improve how patients are treated in future. Participants with IMID diagnoses will be recruited from rheumatology/cardiology departments as in-patients or outpatients. Once consented, researchers will collect past, present and future clinical information about them, including routine cardiovascular imaging and blood tests. Participants will also be asked to complete questionnaires at predetermined intervals. The participants could also be approached to take part in the following sub-studies; Biological sub-study, in which blood and urine would be collected; And the Imaging-sub study, in which one or more of Echocardiography, Cardiovascular Magnetic Resonance Imaging (CMR) and Laser Doppler Imaging (LDI) will be performed. Participants with CVD without IMID and healthy volunteers will also be recruited as comparison groups. The research is to be funded by the NIHR Manchester BRC ('Integrated Cardiovascular' and 'Rheumatic \& Musculoskeletal Diseases' themes). Other funding eg Manchester Academic Health Sciences and a recently awarded Medical Research Council Partnership grant will also support this programme. The study will recruit in specialist NHS centres; Recruitment will start in Manchester University Hospitals NHS Foundation Trust.

Eligibility Criteria

Main Study Inclusion Criteria: * Males and females * Subjects aged over 18 years * Capable of providing informed consent and signing a consent form * Have a clear diagnosis of an IMID with history consistent with one of the following categories: * IMID-'at risk' CVD: individuals who have a risk of developing CVD (based on traditional risk factors and/or IMID-specific factors) but no history of major adverse cardiovascular events (MACE). * Incident (new) IMID-CVD: Patients with IMID that present with a MACE. * Established IMID-CVD: Patients with IMID and a history of previous MACE Exclusion Criteria: * Age less than 18 years * Lack of capacity to give informed consent Imaging Sub-Study Inclusion Criteria: \- As-listed for Main Study Exclusion Criteria: * As-listed for Main Study and; * For the research cardiac MRI imaging component, the following exclusions will apply: pacemakers, surgical clips within the head, certain inner ear implants, neuro-electrical stimulators or metal fragments

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}